These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30717273)

  • 21. Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events.
    Levy Y; Shenkman B; Tamarin I; Pauzner R; Shoenfeld Y; Langevitz P; Savion N; Varon D
    Arthritis Rheum; 2005 Dec; 52(12):4011-7. PubMed ID: 16320349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human neutrophil alpha-defensins induce formation of fibrinogen and thrombospondin-1 amyloid-like structures and activate platelets via glycoprotein IIb/IIIa.
    Horn M; Bertling A; Brodde MF; Müller A; Roth J; Van Aken H; Jurk K; Heilmann C; Peters G; Kehrel BE
    J Thromb Haemost; 2012 Apr; 10(4):647-61. PubMed ID: 22268819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of mean platelet volume in predicting thrombotic events.
    Colkesen Y; Muderrisoglu H
    Clin Chem Lab Med; 2012 Apr; 50(4):631-4. PubMed ID: 22112054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleotide-binding oligomerization domain 2 receptor is expressed in platelets and enhances platelet activation and thrombosis.
    Zhang S; Zhang S; Hu L; Zhai L; Xue R; Ye J; Chen L; Cheng G; Mruk J; Kunapuli SP; Ding Z
    Circulation; 2015 Mar; 131(13):1160-70. PubMed ID: 25825396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-vessel wall interaction in health and disease.
    Löwenberg EC; Meijers JC; Levi M
    Neth J Med; 2010 Jun; 68(6):242-51. PubMed ID: 20558854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelets and platelet-derived microparticles in vascular inflammatory disease.
    Vasina E; Heemskerk JW; Weber C; Koenen RR
    Inflamm Allergy Drug Targets; 2010 Dec; 9(5):346-54. PubMed ID: 21054257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response to platelet-activating factor of platelets from patients with multiple sclerosis.
    Khan SN; Belin J; Smith AD; Sidey M; Zilkha KJ
    Acta Neurol Scand; 1985 Mar; 71(3):212-20. PubMed ID: 3993327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-Specific p38α Deficiency Improved Cardiac Function After Myocardial Infarction in Mice.
    Shi P; Zhang L; Zhang M; Yang W; Wang K; Zhang J; Otsu K; Huang G; Fan X; Liu J
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):e185-e196. PubMed ID: 28982666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet mediated complement activation.
    Peerschke EI; Yin W; Ghebrehiwet B
    Adv Exp Med Biol; 2008; 632():81-91. PubMed ID: 19025116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet microparticles in cryopreserved platelets: Potential mediators of haemostasis.
    Johnson L; Raynel S; Seghatchian J; Marks DC
    Transfus Apher Sci; 2015 Oct; 53(2):146-52. PubMed ID: 26549672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adhesion between neutrophils and platelets: a modulator of thrombotic and inflammatory events?
    Nash GB
    Thromb Res; 1994; 74 Suppl 1():S3-11. PubMed ID: 8073400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet activation markers in evaluation of thrombotic risk factors in various clinical settings.
    Kannan M; Ahmad F; Saxena R
    Blood Rev; 2019 Sep; 37():100583. PubMed ID: 31133440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Pinsky DJ; Islam N; Maliszewsk CR
    Ital Heart J; 2001 Nov; 2(11):824-30. PubMed ID: 11770867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The complexity of platelet metabolism and its contribution to atherothrombosis.
    Puddu P; Muscari A; Puddu GM; Cravero E; Giannoni C; Zoli M
    Acta Cardiol; 2009 Apr; 64(2):157-65. PubMed ID: 19476106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maresin 1 induces a novel pro-resolving phenotype in human platelets.
    Lannan KL; Spinelli SL; Blumberg N; Phipps RP
    J Thromb Haemost; 2017 Apr; 15(4):802-813. PubMed ID: 28079976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transfusion of Platelets Loaded With Recombinant ADAMTS13 (A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13) Is Efficacious for Inhibiting Arterial Thrombosis Associated With Thrombotic Thrombocytopenic Purpura.
    Abdelgawwad MS; Cao W; Zheng L; Kocher NK; Williams LA; Zheng XL
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2731-2743. PubMed ID: 30354235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-neutrophil interactions as drivers of inflammatory and thrombotic disease.
    Lisman T
    Cell Tissue Res; 2018 Mar; 371(3):567-576. PubMed ID: 29178039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelets in Inflammatory Disorders: A Pathophysiological and Clinical Perspective.
    Thachil J
    Semin Thromb Hemost; 2015 Sep; 41(6):572-81. PubMed ID: 26276938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice.
    Baumgartner CK; Mattson JG; Weiler H; Shi Q; Montgomery RR
    J Thromb Haemost; 2017 Jan; 15(1):98-109. PubMed ID: 27496751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen.
    Knight CG; Morton LF; Onley DJ; Peachey AR; Ichinohe T; Okuma M; Farndale RW; Barnes MJ
    Cardiovasc Res; 1999 Feb; 41(2):450-7. PubMed ID: 10341844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.